Cure My Disease

Don't miss your cure!

 Log in / Sign up

Searching for better stroke recovery: new dosing tested

NCT ID NCT03346538

Terminated Disease control Sponsor: Tanabe Pharma Corporation Source: ClinicalTrials.gov ↗

Summary

This study aimed to find the best dose of the drug MCI-186 (edaravone) for people who recently had a stroke. It compared a new continuous infusion method against the standard twice-daily injections to see which was more effective at improving recovery and safer. The trial was small and ended early, so the results are limited.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational site 01

    Hokkaido, Japan

  • Investigational site 02

    Gunma, Japan

  • Investigational site 03

    Osaka, Japan

  • Investigational site 04

    Yamaguchi, Japan

  • Investigational site 05

    Fukuoka, Japan

  • Investigational site 06

    Hyōgo, Japan

  • Investigational site 07

    Fukushima, Japan

  • Investigational site 08

    Fukushima, Japan

  • Investigational site 09

    Fukuoka, Japan

  • Investigational site 10

    Fukui, Japan

  • Investigational site 11

    Fukuoka, Japan

  • Investigational site 12

    Fukuoka, Japan

  • Investigational site 13

    Aichi, Japan

  • Investigational site 14

    Shimane, Japan

  • Investigational site 15

    Gifu, Japan

  • Investigational site 16

    Nagano, Japan

  • Investigational site 17

    Tokyo, Japan

  • Investigational site 18

    Fukuoka, Japan

  • Investigational site 19

    Chiba, Japan

  • Investigational site 20

    Nagano, Japan

  • Investigational site 21

    Fukuoka, Japan

  • Investigational site 22

    Hokkaido, Japan

  • Investigational site 23

    Gifu, Japan

  • Investigational site 24

    Kochi, Japan

  • Investigational site 25

    Osaka, Japan

  • Investigational site 26

    Yamaguchi, Japan

  • Investigational site 27

    Numakunai, Japan

  • Investigational site 28

    Chiba, Japan

  • Investigational site 29

    Tochigi, Japan

  • Investigational site 30

    Hyōgo, Japan

  • Investigational site 31

    Saitama, Japan

  • Investigational site 32

    Fukuoka, Japan

  • Investigational site 33

    Ehime, Japan

  • Investigational site 34

    Yamagata, Japan

  • Investigational site 35

    Miyagi, Japan

  • Investigational site 36

    Tochigi, Japan

  • Investigational site 37

    Fukuoka, Japan

  • Investigational site 38

    Saga, Japan

  • Investigational site 39

    Aomori, Japan

  • Investigational site 40

    Kanagawa, Japan

  • Investigational site 41

    Okinawa, Japan

  • Investigational site 42

    Hyōgo, Japan

  • Investigational site 43

    Ishikawa, Japan

  • Investigational site 44

    Okayama, Japan

  • Investigational site 45

    Tokyo, Japan

Conditions

Explore the condition pages connected to this study.

ACUTE ISCHEMIC STROKE